The National Advertising Division formally recommended in July that the company stop making a wide range of advertising claims and stop promoting many of its user testimonials. Neurocore is appealing the decision.
On February 10, the group alerted Neurocore that it was opening an investigation into the company's advertising claims.
Subsequently, DeVos or one of her immediate family members invested more than $1 million and maybe more than $5 million.
The National Advertising Division said the investigation was initiated in part because Neurocore's claims appear to target “uniquely vulnerable” audiences.
Coming later, Neurocore's expansion and the overselling of its treatment.

No comments:
Post a Comment